Insulin resistance and liver histopathology in metabolically unhealthy subjects do not correlate with the hepatic abundance of NLRP3 inflammasome nor circulating IL-1β levels
Introduction Systemic chronic low-grade inflammation has been linked to insulin resistance (IR) and non-alcoholic steatohepatitis (NASH). NOD-like receptor protein 3 (NLRP3) inflammasome and its final product, interleukin (IL)-1β, exert detrimental effects on insulin sensitivity and promote liver in...
Main Authors: | Nicolas Quezada, Ilse Valencia, Javiera Torres, Gregorio Maturana, Jaime Cerda, Juan Pablo Arab, Juan José Fuentes, Claudio Pinto, Dannae Turiel, Victor Cortés |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-08-01
|
Series: | BMJ Open Diabetes Research & Care |
Online Access: | https://drc.bmj.com/content/9/1/e001975.full |
Similar Items
-
Inhibiting the NLRP3 Inflammasome
by: Lina Y. El-Sharkawy, et al.
Published: (2020-11-01) -
The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
by: Yang Gyun Kim, et al.
Published: (2019-11-01) -
Vitamin D and the NLRP3 Inflammasome
by: Matthew Tunbridge, et al.
Published: (2020-11-01) -
Role of the NLRP3 Inflammasome in Preeclampsia
by: Koumei Shirasuna, et al.
Published: (2020-02-01) -
Regulation of NLRP3 Inflammasome by Phosphorylation
by: Nan Song, et al.
Published: (2018-10-01)